https://www.selleckchem.com/pr....oducts/Adriamycin.ht
We examined the implementation of a brief, behavioural activation (BA) model, via telemedicine, for perinatal populations during a confluence of significant global events in 2020. We conducted a rigorous qualitative study to identify relevant barriers and facilitators from the perspectives of both perinatal participants and treatment providers. We also present two case studies where BA was used and adapted to provide patient-centered care. Within the ongoing SUMMIT non-inferiority randomized controlled trial in Canada and USA, we int
Like
Comment
Share
